Taysha Gene Therapies, Inc. (NASDAQ: TSHA)

Market Cap: 687.824M
Beta: 0.95
P/E Ratio: -0.85
Overall Risk: Medium

TSHA presents a bullish short-term setup, trading above its 50- and 200-day moving averages with strong volume momentum and rising institutional ownership (62.4%). The stock is forming higher highs and higher lows, with resistance at $2.67 and support near $2.56. A recent analyst's upgrade to "Buy" and a strong earnings beat support further upside, especially ahead of the August 11 earnings. However, traders should be cautious of potential pullbacks due to recent volatility, limited profitability (negative EPS and margins), and the possibility of profit-taking near resistance. Short-term outlook: positive, but monitor closely for consolidation or rejection near $2.67.

The Golden Star was indicated on Friday, July 18, 2025, in the short-term chart. (Want to trade but not sure how? Our step-by-step guide can help. )

Palantir Technologies closed at $149.07 on July 22, 2025, down 1.79%, after trading between $145.06 and $151.79. The stock remains in a strong uptrend, holding well above its 50-day ($134.85) and 200-day ($91.96) moving averages. A positive MACD (2.41) supports bullish momentum, but an RSI of 79 signals overbought conditions and possible short-term pullback. ATR at 3.67 suggests moderate volatility, with support at $131.78, resistance at $149.15, and a suggested stop-loss at $143.84. Watch today’s video analysis for key levels and short-term price predictions >>